The Filing Desk

MediciNova vs Mereo BioPharma Group

MediciNova MNOV · Mereo BioPharma Group MREO · Pharmaceuticals

Mereo BioPharma Group reported revenue of $0 million in fiscal 2025, 1.2 times MediciNova's $0 million in fiscal 2025. MediciNova had an operating margin of -3242.5%, against -8021.4% at Mereo BioPharma Group. Free cash flow was −$10 million at MediciNova and −$31 million at Mereo BioPharma Group.

Side by side

MediciNovaMereo BioPharma Group
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$0M$0M
Revenue growth——
Revenue growth a year, last 5 years——
Gross margin——
Operating margin−3,242.5%−8,021.4%
Net margin−2,928.8%−8,375.6%
Free cash flow−$10M−$31M
Free cash flow margin−2,395.4%−6,198.2%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count0.0%7.8%
Last close$1.27$0.28
P/E at the last close——
Insider trades, last 12 monthssold $1.7 million—
Piotroski F-score—4 of 8
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
MediciNovaMereo BioPharma Group
Operating margin
Percent of revenue
MediciNovaMereo BioPharma Group
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
MediciNovaMereo BioPharma Group

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the MediciNova and Mereo BioPharma Group pages.